Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125777222 | 12577722 | 2 | F | 20160805 | 20160721 | 20160814 | EXP | CA-AMGEN-CANSL2016091926 | AMGEN | 88.00 | YR | E | M | Y | 0.00000 | 20160814 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125777222 | 12577722 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 60 MG | U | 21688 | 60 | MG | TABLET | BID | |||||
| 125777222 | 12577722 | 2 | C | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | UNK UNK, TID | 0 | TID | ||||||||||
| 125777222 | 12577722 | 3 | C | REPLAVITE | 2 | UNK UNK, QD | 0 | QD | |||||||||||
| 125777222 | 12577722 | 4 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125777222 | 12577722 | 5 | C | PMS-CARVEDILOL | 2 | 6.25 MG, BID | 0 | 6.25 | MG | BID | |||||||||
| 125777222 | 12577722 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 125777222 | 12577722 | 7 | C | ASA | ASPIRIN | 1 | 0 | ||||||||||||
| 125777222 | 12577722 | 8 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | 1 MG, AS NECESSARY | 0 | 1 | MG | |||||||||
| 125777222 | 12577722 | 9 | C | NTG | NITROGLYCERIN | 1 | PATCH | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125777222 | 12577722 | 1 | Hyperparathyroidism secondary |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125777222 | 12577722 | OT |
| 125777222 | 12577722 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125777222 | 12577722 | Decreased appetite | |
| 125777222 | 12577722 | Diarrhoea | |
| 125777222 | 12577722 | Dizziness | |
| 125777222 | 12577722 | Lethargy | |
| 125777222 | 12577722 | Muscular weakness | |
| 125777222 | 12577722 | Musculoskeletal disorder | |
| 125777222 | 12577722 | Pain | |
| 125777222 | 12577722 | Pneumonia | |
| 125777222 | 12577722 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125777222 | 12577722 | 1 | 20160505 | 0 |